Winning the go-to-market game: Standing out in tomorrow’s complex healthcare ecosystems

Less than 1 min read

Blog, Commercial, Commercialization & Growth

Ahead of Reuters Pharma 2022, Antonio Iervolino, Partner out of our Putnam London office describes 5 major shifts that pharma companies will have to embrace as they design the path to market for their novel assets and provides an analysis on pharma product launches since 2018, identifying trends and measuring their performance against pre-launch expectations.

Antonio distills the key drivers that are critical in developing a virtuous Value Creating System and designing impactful go-to-market strategies for tomorrow’s healthcare ecosystems.

Read more on the thoughtful analysis and hear from Antonio at Pharma 2022 next week.

Download the Whitepaper

Insights

More insights.

See all insights

Vikram Gosain

Lessons to optimize EMA regulatory success using single-arm trials in oncology

We set out to understand the likelihood of regulatory approval of oncology-based single-arm trials by the European Medical Agency (EMA).

Scott Briggs

Medicare Price Negotiation: Putnam’s Round One Picks

As provisions of the Inflation Reduction Act (IRA) of 2022 begin to take effect, Putnam continues to analyze the implications…

Ankit Patel

A new model for driving patient engagement in healthcare

Supporting and empowering patients are objectives stated by nearly every life science company. Yet efforts to support patient engagement often...

Centers of Excellence